US Stock MarketDetailed Quotes

PROK ProKidney

Watchlist
  • 1.610
  • +0.010+0.63%
Close Feb 14 16:00 ET
  • 1.600
  • -0.010-0.62%
Post 17:39 ET
206.03MMarket Cap-2.98P/E (TTM)

About ProKidney Company

ProKidney Corp(formerly Social Capital Suvretta Holdings Corp. III) is an advanced biotechnology company founded by innovators. The company was founded on 2015, is a pioneer in the innovative treatment of chronic kidney disease (CKD) through cell therapy.

Company Profile

SymbolPROK
Company NameProKidney
Listing DateJun 30, 2021
Founded2015
CEODr. Bruce Culleton, M.D.
MarketNASDAQ
Employees163
Fiscal Year Ends12-31
Address2000 Frontis Plaza Boulevard,Suite 250
CityWinston-Salem
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27103
Phone1-336-999-7028

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Bruce Culleton, M.D.
  • Chief Executive Officer and Director
  • 8.71M
  • James Coulston, C.P.A.
  • Chief Financial Officer and Principal Accounting Officer
  • 2.29M
  • Dr. Darin J. Weber, PhD
  • Chief Regulatory Officer and Senior Vice President, Global Regulatory, Quality Management and Commercial
  • --
  • Todd C. Girolamo, J.D.,M.B.A.
  • Chief Legal Officer
  • 2.30M
  • Lucio Tozzi
  • Senior Vice President, Global Clinical Operations
  • --
  • Dr. Ulrich Ernst, PhD
  • Executive Vice President, Technical Operations
  • --
  • Pablo Legorreta
  • Chairman of the Board
  • 434.10K
  • Jose Ignacio Jimenez Santos
  • Independent Director
  • 404.60K
  • Dr. Uma Sinha, PhD
  • Independent Director
  • 410.60K
  • Dr. Brian J.G. Pereira,M.D.
  • Independent Director
  • 421.10K
  • William F. Doyle
  • Independent Director
  • 413.10K
  • Dr. Alan M. Lotvin, M.D.
  • Independent Director
  • 423.60K
  • Jennifer A. Fox
  • Independent Director
  • 749.64K

Trending Stocks

Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More